Chris Reidy May 23, 2013 Spyros Artavanis-Tsakonas, HMS professor of cell biology, has been appointed to the post of chief scientific officer of Biogen Idec Inc., the Weston biotechnology company perhaps best known for its multiple sclerosis drugs announced. Read full article
How Much Are Concierge Medicine and Direct Primary Care Growing? December 18, 2025 Study quantifies surge transforming U.S. health care
Harvard Medical School’s Top Science News of 2025 December 18, 2025 10 biomedical discoveries that expand knowledge, may improve health
Researchers Discover Bias in AI Models That Analyze Pathology Samples December 16, 2025 The team created a new tool that reduces bias and improves cancer diagnosis across populations
